Ribosomal Dysregulation in Metastatic Laryngeal Squamous Cell Carcinoma: Proteomic Insights and CX-5461's Therapeutic Promise

Miao Gao,Ting Liu,Kairui Hu,Songling Chen,Shixin Wang,Di Gan,Zhihan Li,Xiaohuang Lin

DOI: https://doi.org/10.3390/toxics12050363

2024-05-14

Toxics

Abstract:One of the main barriers to the successful treatment of laryngeal squamous cell carcinoma (LSCC) is postoperative progression, primarily due to tumor cell metastasis. To systematically investigate the molecular characteristics and potential mechanisms underlying the metastasis in laryngeal cancer, we carried out a TMT-based proteomic analysis of both cancerous and adjacent non-cancerous tissues from 10 LSCC patients with lymph node metastasis (LNM) and 10 without. A total of 5545 proteins were quantified across all samples. We identified 57 proteins that were downregulated in LSCC with LNM, which were enriched in cell adhesion pathways, and 69 upregulated proteins predominantly enriched in protein production pathways. Importantly, our data revealed a strong correlation between increased ribosomal activity and the presence of LNM, as 18 ribosomal subunit proteins were found to be upregulated, with RPS10 and RPL24 being the most significantly overexpressed. The potential of ribosomal proteins, including RPS10 and RPL24, as biomarkers for LSCC with LNM was confirmed in external validation samples (six with LNM and six without LNM) using Western blotting and immunohistochemistry. Furthermore, we have confirmed that the RNA polymerase I inhibitor CX-5461, which impedes ribosome biogenesis in LSCC, also decreases the expression of RPS10, RPL24, and RPS26. In vitro experiments have revealed that CX-5461 moderately reduces cell viability, while it significantly inhibits the invasion and migration of LSCC cells. It can enhance the expression of the epithelial marker CDH1 and suppress the expression of the mesenchymal markers CDH2, VIM, and FN at a dose that does not affect cell viability. Our study broadens the scope of the proteomic data on laryngeal cancer and suggests that ribosome targeting could be a supplementary therapeutic strategy for metastatic LSCC.

environmental sciences,toxicology

What problem does this paper attempt to address?

### Problems the paper attempts to solve

This paper aims to explore the molecular characteristics and potential mechanisms related to lymph node metastasis (LNM) in laryngeal squamous cell carcinoma (LSCC). Specifically, through tandem mass tag (TMT) - based proteomic analysis, the researchers systematically investigated the differences in protein expression in tumor tissues and adjacent non - cancerous tissues of LSCC patients, especially those protein changes related to lymph node metastasis. The main objectives include:

1. **Identify proteins related to LNM**: Through quantitative proteomic analysis, identify proteins closely related to lymph node metastasis in LSCC patients.
2. **Explore ribosome dysfunction**: The study found that the increase in ribosome activity is closely related to the occurrence of LNM, especially the over - expression of certain ribosomal subunit proteins (such as RPS10 and RPL24).
3. **Verify the potential of ribosomal proteins as biomarkers**: Through external validation samples (including patients with and without LNM), confirm the potential of ribosomal proteins (such as RPS10 and RPL24) as biomarkers for LNM in LSCC.
4. **Evaluate the therapeutic potential of CX - 5461**: Study the effect of CX - 5461 (an RNA polymerase I inhibitor) on the invasion and migration of LSCC cells and its effect in inhibiting ribosome biosynthesis.

### Main findings

- **Proteomic analysis**: Through TMT - labeled proteomic analysis of tumor tissues and adjacent non - cancerous tissues of 10 LSCC patients with LNM and 10 without LNM, a total of 5,545 proteins were quantified. The study found that 57 proteins were down - regulated in LSCC with LNM, mainly enriched in the cell adhesion pathway; 69 proteins were up - regulated, mainly enriched in the protein synthesis pathway.
- **Over - expression of ribosomal proteins**: 18 ribosomal subunit proteins were significantly up - regulated in LSCC with LNM, among which the over - expression of RPS10 and RPL24 was the most significant.
- **Therapeutic effect of CX - 5461**: CX - 5461 can reduce the expression of RPS10, RPL24 and RPS26, moderately reduce cell viability, and significantly inhibit the invasion and migration of LSCC cells. In addition, CX - 5461 can also enhance the expression of the epithelial marker CDH1 and inhibit the expression of the mesenchymal markers CDH2, VIM and FN.

### Conclusions

This study revealed the molecular characteristics related to lymph node metastasis in LSCC through proteomic analysis, especially the abnormal activation of ribosome function. These findings not only help to understand the biological mechanisms of LSCC, but also provide potential targets for the development of new treatment strategies. In particular, CX - 5461, as an RNA polymerase I inhibitor, shows the potential to inhibit the invasion and migration of LSCC cells and may become a new method for treating LSCC.